HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 28 filers reported holding HORIZON PHARMA INVT LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,909,000 | +3.6% | 2,000,000 | 0.0% | 0.13% | -67.8% |
| Q1 2018 | $1,843,000 | -72.5% | 2,000,000 | -72.2% | 0.40% | -71.4% |
| Q4 2017 | $6,696,000 | +2.8% | 7,200,000 | 0.0% | 1.39% | +9.5% |
| Q3 2017 | $6,512,000 | -11.3% | 7,200,000 | -14.3% | 1.27% | +92.7% |
| Q2 2017 | $7,345,000 | +19.7% | 8,400,000 | +25.4% | 0.66% | -9.6% |
| Q1 2017 | $6,135,000 | -6.8% | 6,700,000 | -2.9% | 0.73% | -3.6% |
| Q4 2016 | $6,585,000 | +38.4% | 6,900,000 | +40.8% | 0.75% | +15.8% |
| Q3 2016 | $4,759,000 | +51.9% | 4,900,000 | +44.1% | 0.65% | -31.3% |
| Q2 2016 | $3,133,000 | -39.0% | 3,400,000 | -43.3% | 0.95% | +16.3% |
| Q1 2016 | $5,138,000 | – | 6,000,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |